search icon
      blog search icon

      Appian (APPN) Stock Spiked After Analyst Upgrade

      By Fahim Awan

      Published on

      November 8, 2023

      12:41 PM UTC

      Appian (APPN) Stock Spiked After Analyst Upgrade

      The shares of Appian Corporation (NASDAQ: APPN) embarked on an incremental ascent this Tuesday, surging by 2.27% to conclude the day’s trading at $38.25. This shift in the trajectory of Appian’s stock was prompted by an upward revision in analyst recommendations. On November 7, 2023, DA Davidson elevated its endorsement for APPN shares, transitioning from a “Neutral” stance to a “Buy” rating. The firm also raised the price target for the stock to $55, a notable increase from its previous level of $50.

      Odesso Health stands as a pioneering force in the integration of artificial intelligence (AI) to automate Electronic Medical Records (EMR) workflows. It recently unveiled its Clinical Data Connector (CDC) in both the athenahealth Marketplace and the Appian Community AppMarket.

      Hinging on the Appian platform, Odesso Health’s CDC automates the processes of document scrutiny, data extraction, and the generation of critical quality metrics for EMRs (Electronic Health Records) and EHRs (Electronic Health Records). With a growing shift within the healthcare sector towards a value-based care model, where fees are contingent on patient outcomes, the precise tracking of vital metrics such as blood sugar levels, blood pressure, and body mass index has become imperative.

      The CDC employs application program interfaces (APIs) to autonomously extract patient data from clinical documentation and leverages AI and machine learning (ML) to enhance data quality while concurrently reducing costs associated with value-based care contracts. Additionally, it delivers a scalable EMR management solution by eliminating the need for manual data entry.

      Odesso’s CDC, founded upon the Appian Platform, harnesses the prowess of AI-powered process automation to enhance efficiency, data integrity, and cost reduction within healthcare EMR workflows. In this manner, Appian is facilitating healthcare providers in their embrace of value-based care and the streamlining of operational procedures, ultimately enhancing patient care outcomes.

      Furthermore, in collaboration with Guidewire, Appian has also introduced its new “Ready for Guidewire” integration for Guidewire Cloud users within the Guidewire Marketplace. Leveraging the capabilities of artificial intelligence (AI), Appian’s Process Automation platform empowers insurers to streamline their enterprise processes by seamlessly integrating multiple systems and automating workflows, thereby enhancing operational efficiency.

      Appian’s technology enables insurers to swiftly construct applications and workflows using a low-code app development approach, sophisticated workflow management, automation tools, robotic process automation (RPA), and process mining.

      More From Stocks telegraph